948 related articles for article (PubMed ID: 30760612)
1. VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant
Taglialegna A; Varela MC; Rosato RR; Rosato AE
mSphere; 2019 Feb; 4(1):. PubMed ID: 30760612
[TBL] [Abstract][Full Text] [Related]
2. VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus.
Mehta S; Cuirolo AX; Plata KB; Riosa S; Silverman JA; Rubio A; Rosato RR; Rosato AE
Antimicrob Agents Chemother; 2012 Jan; 56(1):92-102. PubMed ID: 21986832
[TBL] [Abstract][Full Text] [Related]
3. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S
Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
[TBL] [Abstract][Full Text] [Related]
4. Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates.
Bertsche U; Yang SJ; Kuehner D; Wanner S; Mishra NN; Roth T; Nega M; Schneider A; Mayer C; Grau T; Bayer AS; Weidenmaier C
PLoS One; 2013; 8(6):e67398. PubMed ID: 23785522
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of the two-component system and cell-wall biosynthesis-related genes was associated with the reversion to daptomycin susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus.
Iwata Y; Satou K; Tsuzuku H; Furuichi K; Senda Y; Sakai-Takemori Y; Wada T; Fujita S; Miyake T; Yasuda H; Sakai N; Kitajima S; Toyama T; Shinozaki Y; Sagara A; Miyagawa T; Hara A; Shimizu M; Kamikawa Y; Kaneko S; Wada T
Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1839-1845. PubMed ID: 28477235
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.
Kang KM; Mishra NN; Park KT; Lee GY; Park YH; Bayer AS; Yang SJ
J Microbiol; 2017 Feb; 55(2):153-159. PubMed ID: 28120188
[TBL] [Abstract][Full Text] [Related]
7. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA).
Thitiananpakorn K; Aiba Y; Tan XE; Watanabe S; Kiga K; Sato'o Y; Boonsiri T; Li FY; Sasahara T; Taki Y; Azam AH; Zhang Y; Cui L
Sci Rep; 2020 Sep; 10(1):16107. PubMed ID: 32999359
[TBL] [Abstract][Full Text] [Related]
8. Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations.
Kanesaka I; Fujisaki S; Aiba Y; Watanabe S; Mikawa T; Katsuse AK; Takahashi H; Cui L; Kobayashi I
J Infect Chemother; 2019 Jan; 25(1):1-5. PubMed ID: 30322736
[TBL] [Abstract][Full Text] [Related]
9. Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides.
Bayer AS; Mishra NN; Chen L; Kreiswirth BN; Rubio A; Yang SJ
Antimicrob Agents Chemother; 2015 Aug; 59(8):4930-7. PubMed ID: 26055370
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.
Bayer AS; Mishra NN; Sakoulas G; Nonejuie P; Nast CC; Pogliano J; Chen KT; Ellison SN; Yeaman MR; Yang SJ
Antimicrob Agents Chemother; 2014 Dec; 58(12):7462-7. PubMed ID: 25288091
[TBL] [Abstract][Full Text] [Related]
11. Molecular Bases Determining Daptomycin Resistance-Mediated Resensitization to β-Lactams (Seesaw Effect) in Methicillin-Resistant Staphylococcus aureus.
Renzoni A; Kelley WL; Rosato RR; Martinez MP; Roch M; Fatouraei M; Haeusser DP; Margolin W; Fenn S; Turner RD; Foster SJ; Rosato AE
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795377
[TBL] [Abstract][Full Text] [Related]
12. Emergence of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Clinical Isolates Among Daptomycin-Naive Patients in Korea.
Nam EY; Yang SJ; Kim ES; Cho JE; Park KH; Jung SI; Yoon N; Kim DM; Lee CS; Jang HC; Park Y; Lee KS; Kwak YG; Lee JH; Park SY; Hwang JH; Kim M; Song KH; Kim HB
Microb Drug Resist; 2018 Jun; 24(5):534-541. PubMed ID: 29863982
[TBL] [Abstract][Full Text] [Related]
13. VraT/YvqF is required for methicillin resistance and activation of the VraSR regulon in Staphylococcus aureus.
Boyle-Vavra S; Yin S; Jo DS; Montgomery CP; Daum RS
Antimicrob Agents Chemother; 2013 Jan; 57(1):83-95. PubMed ID: 23070169
[TBL] [Abstract][Full Text] [Related]
14. dltA overexpression: A strain-independent keystone of daptomycin resistance in methicillin-resistant Staphylococcus aureus.
Cafiso V; Bertuccio T; Purrello S; Campanile F; Mammina C; Sartor A; Raglio A; Stefani S
Int J Antimicrob Agents; 2014 Jan; 43(1):26-31. PubMed ID: 24183798
[TBL] [Abstract][Full Text] [Related]
15. Emergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms.
Mishra NN; Yang SJ; Chen L; Muller C; Saleh-Mghir A; Kuhn S; Peschel A; Yeaman MR; Nast CC; Kreiswirth BN; Crémieux AC; Bayer AS
PLoS One; 2013; 8(8):e71151. PubMed ID: 23990934
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons.
Mishra NN; Bayer AS; Weidenmaier C; Grau T; Wanner S; Stefani S; Cafiso V; Bertuccio T; Yeaman MR; Nast CC; Yang SJ
PLoS One; 2014; 9(9):e107426. PubMed ID: 25226591
[TBL] [Abstract][Full Text] [Related]
17. β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.
Mehta S; Singh C; Plata KB; Chanda PK; Paul A; Riosa S; Rosato RR; Rosato AE
Antimicrob Agents Chemother; 2012 Dec; 56(12):6192-200. PubMed ID: 22985884
[TBL] [Abstract][Full Text] [Related]
18. Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance.
Ernst CM; Slavetinsky CJ; Kuhn S; Hauser JN; Nega M; Mishra NN; Gekeler C; Bayer AS; Peschel A
mBio; 2018 Dec; 9(6):. PubMed ID: 30563904
[TBL] [Abstract][Full Text] [Related]
19. Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus.
Ma Z; Lasek-Nesselquist E; Lu J; Schneider R; Shah R; Oliva G; Pata J; McDonough K; Pai MP; Rose WE; Sakoulas G; Malik M
PLoS One; 2018; 13(6):e0198366. PubMed ID: 29879195
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin tolerance in methicillin-resistant Staphylococcus aureus: influence of vancomycin, daptomycin, and telavancin on differential resistance gene expression.
Rose WE; Fallon M; Moran JJ; Vanderloo JP
Antimicrob Agents Chemother; 2012 Aug; 56(8):4422-7. PubMed ID: 22687502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
